2006
DOI: 10.1016/j.taap.2006.06.014
|View full text |Cite
|
Sign up to set email alerts
|

Glutathione-S-transferase-omega [MMA(V) reductase] knockout mice: Enzyme and arsenic species concentrations in tissues after arsenate administration☆

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
42
0

Year Published

2007
2007
2014
2014

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 79 publications
(70 citation statements)
references
References 64 publications
1
42
0
Order By: Relevance
“…[22][23][24] The third mutation was a mutation in CWF19L1 in an obligatory splice site (c.96411G.A, i.e., the first base of intron 9, always G, is changed to an A; figure 1D). Sanger sequencing confirmed this mutation in the affected siblings and demonstrated that it is absent in 200 Turkish individuals without neurologic disorder.…”
Section: Results Exome Sequencing Identifies Mutation Inmentioning
confidence: 99%
“…[22][23][24] The third mutation was a mutation in CWF19L1 in an obligatory splice site (c.96411G.A, i.e., the first base of intron 9, always G, is changed to an A; figure 1D). Sanger sequencing confirmed this mutation in the affected siblings and demonstrated that it is absent in 200 Turkish individuals without neurologic disorder.…”
Section: Results Exome Sequencing Identifies Mutation Inmentioning
confidence: 99%
“…Recently, GSTOs were shown to scavenge free radicals and ROS by modulating dehydroascorbate reduction and recycling (Rice 2000;Burmeister et al 2008). GSTOs also participate in the biotransformation pathway of inorganic arsenic metabolism, which protects organisms from acute and chronic arsenic toxicosis (Chowdhury et al 2006). There is increasing evidence that GSTOs are involved in various biological and clinically significant settings, including drug resistance (Yin et al 2005), Alzheimer's disease (Li et al 2003), the action of anti-inflammatory drugs (Laliberte et al 2003), and susceptibility to chronic obstructive pulmonary disease (COPD) (Dulhunty et al 2001).…”
Section: Introductionmentioning
confidence: 99%
“…This enzyme had considerable sequence homology to glutathione-S-transferase omega (GSTO) (Zakharyan et al, 2001), suggesting that reduction of MMA(V) was a function of GSTO. However, studies in GSTO knockout mice found no effect of the null genotype on the disposition and metabolism of arsenicals in tissues after treatment with inorganic As(V) (Chowdhury et al, 2006).…”
Section: Reduction Of As(v)mentioning
confidence: 99%